Startseite Expression of a functional recombinant vascular endothelial growth factor 165 (VEGF165) in Arabidopsis thaliana
Artikel Öffentlich zugänglich

Expression of a functional recombinant vascular endothelial growth factor 165 (VEGF165) in Arabidopsis thaliana

  • Weidong Qiang , Xue Feng , Yixin Li , Xinxin Lan , Kun Ji , Xiaoyu Sun , Xi Chen , Haiyan Li EMAIL logo , Linna Du EMAIL logo und Jing Yang ORCID logo EMAIL logo
Veröffentlicht/Copyright: 15. August 2018
Artikel downloaden (PDF)
Turkish Journal of Biochemistry
Aus der Zeitschrift Turkish Journal of Biochemistry Band 44 Heft 3

Abstract

Objective

Targeting the protein of interest to a particular tissue to achieve high-level expression is an important strategy to increase expression efficiency. The use of the plant seed oil body as a bioreactor can not only increase the amount of target protein, but also reduce the cost of downstream processing.

Methods

VEGF165 was expressed in Arabidopsis thaliana seeds via oilbody fusion technology. The pKO-VEGF165 vector was construted and transformed into A. thaliana seeds. T3 transgenic seeds was detected by SDS-PAGE and western blot methods. The cell activity was tested by MTT methods.

Result

The phaseolin promoter was used to drive seed-specific expression of the VEGF165 gene in transgenic A. thaliana. The coding region of VEGF165 was fused to the Arabidopsis oleosin sequence to target the protein to the oil bodies in the seeds of transgenic plants. The T-DNA region of recombinant plasmid pKO-VEGF165 was shifted to A. thaliana seeds via the floral-dip method. Protein was analyzed by electrophoresis and protein hybridization analyses. Finally, MTT assays showed that the oleosin-VEGF165 fusion protein played a part in the proliferation of HUVEC cells in vitro.

Conclusion

Oleosin-VEGF165 was successfully expressed and it had stimulated HUVEC cell proliferation activity.

Öz

Amaç

Yüksek seviyeli ekspresyon elde etmek için ilgili proteinin belirli bir dokuya hedeflenmesi, ekspresyon verimliliğini artırmak için önemli bir stratejidir. Bir biyoreaktör olarak bitki tohum yağı gövdesinin kullanılması, sadece hedef protein miktarını arttırmakla kalmaz, aynı zamanda aşağı akış işleme maliyetini de düşürür.

Metod

VEGF165, yağlı vücut füzyon teknolojisi vasıtasıyla Arabidopsis thaliana tohumlarında eksprese edildi. pKO-VEGF165 vektörü dizilmiş ve Arabidopsis thaliana tohumlarına dönüştürülmüştür. T3 transjenik tohumları SDS-PAGE ve western blot yöntemleri ile tespit edildi. Hücre aktivitesi MTT yöntemleriyle test edildi. Protein, elektroforez ve protein hibridizasyon analizleri ile analiz edildi.

Bulgular

Transazensel Arabidopsis thaliana’daki tohumdan spesifik ekspresyonunu başlatmak için fazoin yükseltici kullanılmıştır. VEGF165, in kodlama bölgesi, proteini transjenik bitkilerin tohumlarındaki yağ gövdelerine hedeflemek için Arabidopsis oleosin dizisine kaynaştırıldı. Rekombinant plazmid pKO-VEGF165, in T-DNA bölgesi, çiçek-daldırma yöntemi vasıtasıyla Arabidopsis thaliana tohumlarına kaydırılmıştır. Finally, MTT assays showed that the oleosin-VEGF165 fusion protein played a part in the proliferation of HUVEC cells in vitro.

Sonuç

Oleozin-VEGF165 başarıyla eksprese edildi ve HUVEC hücre çoğalması aktivitesini uyardı.

Keywords: Vascular endothelial growth factor 165; Oil body; Oleosin; Arabidopsis thaliana
Anahtar Kelimeler: Vasküler endotelyal büyüme faktörü 165; Yağ gövdesi; Oleosini; Arabidopsis thaliana

Introduction

Vascular endothelial growth factor (VEGF) is a dimeric glycoprotein that induces the production of mitogen in endothelial cells [1]. It plays a role in an basal regulator of vasculogenesis and hematopoiesis, wound healing [2], [3], [4] and pathological status such as rheumatoid arthritis, cancer, cardiovascular disease and psoriasis [5], [6], [7], [8]. VEGF can promote vasopermeability, stimulate endothelial cell proliferation and migration [9], and drive neovascularization [10], [11], [12]. The alternative splicing of VEGF-mRNA generated five isoforms (VEGF121, VEGF145, VEGF165, VEGF189, and VEGF206) [13]. A variety of VEGF isoforms are possible to carry out different effects and they synergize in the tumor angiogenesis process. VEGF165 is the most effective angiogenic factor in the VEGF family [13]. The literature reported that increased tumor angiogenesis and poor outcomes correlate with the overexpression of VEGF165 in colon cancer, osteosarcoma, renal cell carcinoma and non-small cell lung cancer [13], [14], [15].

Plants have been used as a source of natural products throughout history, dating back thousands of years. The development of plant transformation technology has led to the use of various plant hosts for the expression of human therapeutics [16], [17], nutraceuticals [18], antibodies [19], [20], industrial enzymes [21], [22], vaccine antigens [23], [24], and biopolymers [25], [26]. The bioactive proteins are produced in the plant bioreactor that is most safe, non-toxic, simple and lowest cost. Although they have some limitations, such as appear to be the carriers for exogenous proteins in seeds, these proteins are produced more stable in plant seeds than other tissues [27]. The purification of the exogenous protein from the wide spectrum is a major bottleneck, because it requires many tedious processes [27]. However, it is easier to extract a recombinant protein located on the surface of an oil body, since oil bodies can be separated easily from other cellular components by flotation centrifugation [27], [28], [29].

After the target protein is anchored on the surface of oil body, the oil bodies can be separated via flotation centrifugation and the oleosin-target protein can be easily extracted [27], [30]. Oil body expressed hirudin was extracted from transgenic seeds and the recombinant hirudin showed anti-thrombin activity [27], [31]. The β-glucuronidase linked to the oil body was detected to be active and remained active after it was separated from the surface of the oil body [27], [32]. Human epidermal growth factor that fused with oleosin and inserted into a chymosin cleavage factor between oleosin-hEGF has been expressed in Arabidopsis thaliana. Here, we expressed VEGF165 targeted to the oil body in A. thaliana. The expression vector pKO-VEGF165 was constructed and the T-DNA region of the recombinant plasmid was transformed into plant genome. The oleosin-VEGF165 fusion protein expressed in the transgenic A. thaliana seeds showed good antigenicity, and it stimulated HUVEC cell proliferation.

Materials and methods

Reagents

Escherichia coli DH5α and Agrobacterium tumefaciens EHA105 were obtained from the team of XK Li professor in Jilin Agricultural University, China. The restriction enzymes such as NcoI and Hind III, ExTaq DNA polymerase were purchased from TaKaRa (Dalian, China). Streptomycin (Str) and Kanamycin (Kam) were obtained from Sigma (Hong Kong, China). Glufosinate was from Boehringer Mannheim Corp [33]. (Mannheim, Germany). The rabbit anti-VEGF polyclonal antibody was acquire from Beijing Bioss Co., Ltd. Goat anti-rabbit IgG was obtained from Promega (Madison, WI, USA). Human umbilical vein endothelial (HUVEC) cells were stored in liquid nitrogen until use. Methylthiazol tetrazolium (MTT) was obtained from Gold Biotechnology (St. Louis, MO, USA) [33], [34]. The M199 medium was purchased from Gibco BRL (Grand Island, NY, USA).

Preparation of the recombinant vector pKO-VEGF165

The pKO plasmid was modifications of the pCAMBIA1301 plasmid vector. The hygromycin resistance gene in pCAMBIA1301 was replaced by the basta gene. The selectable marker basta gene was driven by the CaMV 35S promoter. CaMV 35S promoter (No. AF218816.1), the basta gene (No. AF218816.1), and the nos terminator (No. AF234307), phaseolin promoter/terminator (Patent PCT/US01/47495), the A. thaliana oleosin gene (No. X62353.1) and VEGF165 gene (No. AF486837.1) were obtained from GenBank. The VEGF165 gene was sticked into the pKO vector by NcoI and Hind III (Figure 1). It was designated as pKO-VEGF165, then was shifted into Agrobacterium EHA105 using the freeze-thaw method [35].

Figure 1: Structure chart of recombinant plasmid pKO-VEGF165.The T-DNA of the pKO-VEGF165 vector included a phaseolin promoter/terminator, an Arabidopsis thaliana oleosin gene, VEGF165 gene, the 35S promoter, the bar gene and nos terminator. PhaP, phaseolin promoter; Oleasin, Arabidopsis thaliana oleosin gene, VEGF165, Vascular Endothelial Growth Factor165; PhaT, phaseolin terminator; 35S, CaMV35S promoter; Bar, the glufosinate resistance gene; Nos, Nopaline synthase terminater gene.
Figure 1:

Structure chart of recombinant plasmid pKO-VEGF165.

The T-DNA of the pKO-VEGF165 vector included a phaseolin promoter/terminator, an Arabidopsis thaliana oleosin gene, VEGF165 gene, the 35S promoter, the bar gene and nos terminator. PhaP, phaseolin promoter; Oleasin, Arabidopsis thaliana oleosin gene, VEGF165, Vascular Endothelial Growth Factor165; PhaT, phaseolin terminator; 35S, CaMV35S promoter; Bar, the glufosinate resistance gene; Nos, Nopaline synthase terminater gene.

Transformation into Arabidopsis thaliana

Arabidopsis thaliana (Columbia ecotype) were used for infection. The floral-dip liquid medium which included 1% (w/v) B5 (200×) medium, 100 g/L sucrose, 2 mg/L 6-BA, 1 M sodium hydroxide, and 200 μL Silwet L-77 was prepared as previously described [34]. Plants’ aerial parts were dipped into the medium for 5 min, and then culture dark light for 16–24 h. Then the plants were cultured in light condition. The dry seeds were (T1) were collected in a sample bag.

Protein expression analysis

Arabidopsis thaliana seeds (1 mg) were ground with 40 μL Tris-HCl (50 mM) in 1.5 mL ep tubes. The mixtures that included oil body liquid supernatant and 5×loading buffer were boiled for 10 min, and they were detected on two 12% polyacrylamide gels under reducing conditions. The polyacrylamide gels were colored overnight using Coomassie blue. In the meantime, the gels were electroblotted onto 0.45-μm polyvinylidene difluoride (PVDF) membranes. Electroblotting was carried out at 100 V for 75 min which contained 2.9 g/L glycine, 5.8 g/L Tris, 0.37 g/L SDS and 20% (v/v) methanol [36]. The PVDF membranes were incubated with a rabbit anti-VEGF polyclonal antibody antiserum (1:1000 dilution) and then washed 4 times with TBST. Then the secondary antibody which is goat anti-rabbit IgG/AP antibody (1:5000) incubated for 120 min at 25°C [36]. The PVDF membranes were colored Alkaline Phosphatase.

Activity assay of VEGF165

Seeds (20 mg) were ground in 200 μL Tris-Cl (pH 7.5), and then the mixture was centrifuged at 10,000×g and 4°C for 30 min. The oil body was collected at resuspended in 200 μL Tris-Cl (pH 7.5) [33], and centrifuged again. After centrifugation, the oil body was mixed again with 10 μL Tris-Cl buffer [33]. The biological activity on the proliferation of HUVEC cells was analyzed from transgenic oil body suspension. The HUVEC cells were cultured in M199 medium containing 20% fetal bovine serum (FBS) until they achieved the logarithmic phase. Then, the cells were removed and cultured into a new 96-well plate (8×103/well) with 1% FBS for 24 h. The HUVEC cells were incubated with various dilutions of oleosin-VEGF165 (250, 500, 1000, 2000, 4000, and 8000-times dilutions) or wild-type oil bodies (negative control, diluted 250, 500, 1000, 2000, 4000, and 8000 times) for 48 h. To determine the activity of the cells, 20 μL MTT was added, the cells were incubated for 4 h and 100 μL DMSO was added to each well [37]. After 10 min, the absorbance was measured at 570/630 nm in a Microplate Reader model 450.

Result

Expression Oleosin-VEGF165 in Arabidopsis thaliana and screening for transgenic lines

We constructed the pKO vector cassette linking to the VEGF165 gene to express VEGF165 and VEGF165 gene was inserted into pKO vector (Figure 1). The pKO-VEGF165 plasmid was detected using PCR method and transformed successfully into Agrobacterium EHA105 competent cells by the freeze-thaw method. The VEGF165 gene was anchored on the surface of oil body and it was specifically expressed in A. thaliana seeds [34]. The pKO-VEGF165 plasmid was transformed into A. thaliana by floral-dip method. The infection process was as shown in Figure 2. The T1 transgenic seeds were sown until the plants grew 6–8 leaves. Afterwards the transformants were chosen by 1% (w/v) glufosinate. The cotyledons of non-transformed plants became bleached, while transgenic seedings grew normally. Positively transformed lines were grown and ultimately homozygous seeds were obtained [36]. Four lines (T3-1, T3-2, T3-3, T3-4) were confirmed as positive transformants and were used for further analysis.

Figure 2: The infection and culture process of Arabidopsis thaliana.(A) Arabidopsis thaliana seeds germination. (B) Arabidopsis thaliana culture after transplant. (C) Arabidopsis thaliana plants after infection. (D) T1 Arabidopsis thaliana seeds germination. (E) Screening for transgenic T2 Arabidopsis thaliana plants. (F) Single plant harvesting of T2 Arabidopsis thaliana.
Figure 2:

The infection and culture process of Arabidopsis thaliana.

(A) Arabidopsis thaliana seeds germination. (B) Arabidopsis thaliana culture after transplant. (C) Arabidopsis thaliana plants after infection. (D) T1 Arabidopsis thaliana seeds germination. (E) Screening for transgenic T2 Arabidopsis thaliana plants. (F) Single plant harvesting of T2 Arabidopsis thaliana.

Oleosin-VEGF165 fusion protein expression analysis

To detect whether VEGF165 genes was expressed in the transgenic T3 A. thaliana seeds, oil bodies were extracted from T3 transgenic A. thaliana seeds. Four independent transgenic lines was evaluated by extraction of the oil bodies which expressed oleosin-VEGF165 protein (Figure 3A and B). The accumulate of oleosin-VEGF165 was calculated. The fusion protein were analyzed by SDS-PAGE. The SDS-PAGE results showed that the target band of oleosin-VEGF165 fusion protein was about 36 kDa from T3 transgenic plant T3-1, T3-2, T3-3. The protein from wild type seeds had no band at this position and there was no target band at this position from T3-4 transgenic plant (Figure 3A). To further confirm the presence of 36 kDa oleosin-VEGF165 in the oil body, the immunodetection by rabbit anti-VEGF165 polyclonal antibody was carried out in the experiment. The Oleosin-VEGF165 fusion protein was identified from T3 transgenic plant T3-1, T3-2, T3-3 by the anti-VEGF165 polyclonal antibody (Figure 3B). The hybridization band appeared at 36 kDa from T3 transgenic plant T3-1, T3-2, T3-3 in accordance with the predicted oleosin-VEGF165 fusion protein. However, there was no band at this position in the analysis of the total proteins from wild-type seeds. The VEGF165 gene was expressed in A. thaliana and its product accumulated in the oil bodies in the transgenic seeds.

Figure 3: Identification of SDS-PAGE and western blot of oil bodies in transgenic Arabidopsis thaliana.(A) M: Protein Marker; lane1–lane4: the oil body from T3 transgenic Arabidopsis thaliana T3-1, T3-2, T3-3, T3-4; lane5: the oil bodies from wild-type (WT) Arabidopsis thaliana. (B) Lane 1: oil bodies from T3-1 transgenic Arabidopsis thaliana; lane2: the oil bodies from wild-type Arabidopsis thaliana; lane3–lane4: the oil body from T3 transgenic Arabidopsis thaliana T3-2, T3-3.
Figure 3:

Identification of SDS-PAGE and western blot of oil bodies in transgenic Arabidopsis thaliana.

(A) M: Protein Marker; lane1–lane4: the oil body from T3 transgenic Arabidopsis thaliana T3-1, T3-2, T3-3, T3-4; lane5: the oil bodies from wild-type (WT) Arabidopsis thaliana. (B) Lane 1: oil bodies from T3-1 transgenic Arabidopsis thaliana; lane2: the oil bodies from wild-type Arabidopsis thaliana; lane3–lane4: the oil body from T3 transgenic Arabidopsis thaliana T3-2, T3-3.

Activity assay of VEGF165

According to western blot result, transgenic line T3-1, T3-2, T3-3 were chosen to evaluate the bioactivity of the oleosin-VEGF165 fusion proteins. Because the oil bodies expressed oleosin-VEGF165 was obtained from T3-1, T3-2, T3-3 seeds, these seeds were used to detect the proliferative activity by the MTT method with HUVEC cells. The oil bodies extracted from Line T3-1, T3-2, T3-3 were analyzed. In Figure 4, the x- axis shows the dilution ratio of the oil bodies and the y-axis shows the OD value (Figure 4). A gradient of VEGF165 dilution ratio was used and the dilution ratio was set as a gradient from 250 to 8000 times (Figure 4). The results showed that the oil bodies that expressed oleosin-VEGF165 fusion protein from the T3-1, T3-2, T3-3 had a dose-dependent proliferative effect on HUVEC cells. The wild-type oil bodies used as the negative control did not obviously show this dose-response relationship with cell proliferation.

Figure 4: The activity assay of oil body expressed oleosin-VEGF165 in the transgenic Arabidopsis thaliana seeds.Dose-response curves for proliferation activity. The OD value was changed in HUVEC cells in absorbance (570/630 nm). The test sample included, oil body from wild-type A. thaliana (), oil body expressed oleosin-VEGF165 from T3-1(), oil body expressed oleosin-VEGF165 from T3-2(), oil body expressed oleosin-VEGF165 from T3-3().
Figure 4:

The activity assay of oil body expressed oleosin-VEGF165 in the transgenic Arabidopsis thaliana seeds.

Dose-response curves for proliferation activity. The OD value was changed in HUVEC cells in absorbance (570/630 nm). The test sample included, oil body from wild-type A. thaliana (), oil body expressed oleosin-VEGF165 from T3-1(), oil body expressed oleosin-VEGF165 from T3-2(), oil body expressed oleosin-VEGF165 from T3-3().

Discussion

The plant expression systems can produce active exogenous proteins in many studies [36]. Such systems show great advantages in terms of cost-efficiency, product quality and safety [36]. Oil bodies can also serve as an efficient system for the expression of cellulolytic enzymes [27], because the enzyme is restricted to the cell surface, it is prevented from contacting its substrates (cell wall constituents) in plants [38]. The target protein is expressed in the seed after being linked with the oleosin and oleosin accounts for 2%–10% of the total protein in the seeds. So the expression level of target protein is lower. But the advantage of oil body system is that the target protein need not be purified and the oil body is directly applied to the skin surface. So the oil body expression system represents a perfect system for the production of therapeutic proteins. The oleosin-haFGF protein was expressed in A. thaliana seeds via oleosin fusion technologyand it had biological activity which stimulated NIH/3T3 cell proliferation activity [33]. Human fibroblast growth factor 9 was expressed in A. thaliana oil bodies [34]. Fibroblast growth factor 10 was expressed in Carthamus tinctorius L. seeds [39]. The process of purifying VEGF165 from E. coli cells was more complicated than purifying the protein from the oil body. VEGF165 was targeted to the C-terminus of oleosin and the process of purification was easier. The purification process was simple and refolding of proteins was not required [34], [40]. Oleosins can act as a natural emulsifying and stabilizing agent at oil/water interfaces; therefore, there are many potential applications [34]. It is important to have an economical, reliable, and up-scalable method to synthesize bioactive oleosin-VEGF165 to evaluate such applications. The oil body expression system represents a perfect system for the production of therapeutic proteins. This system has the potential to produce safe, biologically active proteins with low purification costs. When the dilution ratio of oil bodies was 250–4000 times, the absorbance of oil bodies harboring VEGF165 was higher than that of wild-type oil bodies. When the dilution ratio was 8000 times, the absorbance of the transgenic oil bodies began to decline slowly. The oil bodies harboring VEGF165 promoted the proliferation of HUVEC cells in a dose-dependent manner.

Acknowledgments

This work was supported by grants from the National High Technology Research and Development Program (863 program) of China (2011AA100606).

  1. Conflict of interest: The authors have no conflict of interest.

References

1. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9–22.10.1096/fasebj.13.1.9Suche in Google Scholar

2. Ferrara N, Gerber Hans P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–76.10.1038/nm0603-669Suche in Google Scholar PubMed

3. Olsson Anna K, Dimberg A, Kreuger J, Claesson Welsh L. VEGF receptor signaling-in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359–71.10.1038/nrm1911Suche in Google Scholar PubMed

4. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 2002;29:10–4.10.1053/sonc.2002.37264Suche in Google Scholar PubMed

5. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57.10.1038/35025220Suche in Google Scholar PubMed

6. Murakami M, Iwai S, Hiratsuka S, Yamauchi M, Nakamura K, Iwakura Y, et al. Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocyte/macrophages. Blood 2006;108:1849–56.10.1182/blood-2006-04-016030Suche in Google Scholar PubMed

7. Detmar M, Brown LF, Claley KP, Yeo KT, Kocher O, Jackman RW, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994;180:1141–6.10.1084/jem.180.3.1141Suche in Google Scholar PubMed PubMed Central

8. Tammela T, Enholm BK, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005;65:550–63.10.1016/j.cardiores.2004.12.002Suche in Google Scholar PubMed

9. Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem Biophys Res Commun 2006;349:31–8.10.1016/j.bbrc.2006.07.213Suche in Google Scholar PubMed

10. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309–12.10.1126/science.2479987Suche in Google Scholar PubMed

11. Ng YS, Krilleke D, Shima DT. VEGF function in vascular pathogenesis. Exp Cell Res 2006;312:527–37.10.1016/j.yexcr.2005.11.008Suche in Google Scholar PubMed

12. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 1999;18:3964–72.10.1093/emboj/18.14.3964Suche in Google Scholar PubMed PubMed Central

13. Shen HL, Xu WL, Wu ZY, Zhou LL, Qin RJ, Tang HR. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells. Leuk Res 2007;31:515–21.10.1016/j.leukres.2006.09.011Suche in Google Scholar PubMed

14. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25.10.1007/978-1-4613-0389-3_7Suche in Google Scholar

15. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999;77:527–43.10.1007/s001099900019Suche in Google Scholar PubMed

16. Giddings G, Allison G, Brooks D, Carter A. Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol 2000;18:1151–5.10.1038/81132Suche in Google Scholar PubMed

17. Stoger E, Ma JK, Fischer R, Christou P. Sowing the seeds of success: pharmaceutical-proteins from plants. Curr Opin Biotechnol 2005;16:167–73.10.1016/j.copbio.2005.01.005Suche in Google Scholar PubMed

18. Adkins YB, Lonnerdal B. Proteins and peptides. Biotechnology for performance foods, functional foods, and nutraceuticals. NewYork: Marcel Dekker, Inc. Publication, 2004.10.1201/9780203026380.ch10Suche in Google Scholar

19. Arntzen C, Plotkin S, Dodet B. Plant-derived vaccines and antibodies: potential and limitations. Vaccine 2005;23:1753–6.10.1016/j.vaccine.2005.01.090Suche in Google Scholar PubMed

20. Nikolov ZL, Regan JT, Dickey LF, Woodard SL. Purification of antibodies from transgenic plants Chapter 19. USA: John Wiley & Sons, Inc. Publication, 2008.10.1002/9780470444894.ch19Suche in Google Scholar

21. Hood EE, Love R, Lane J, Bray J, Clough R, Pappu K. Subcellular targeting is a key condition for high-level accumulation of cellulose protein in transgenic maize seed. Plant Biotechnol J 2007;5:709–19.10.1111/j.1467-7652.2007.00275.xSuche in Google Scholar PubMed

22. Howard JA, Nikolov ZL, Hood EE. Enzyme production systems for biomass conversion. USA: John Wiley & Sons Inc. Publication, 2011.10.1002/9780470959138.ch10Suche in Google Scholar

23. Ling HY, Pelosi A, Walmsley AM. Current status of plant-made vaccines for veterinary purposes. Expert Rev Vaccines 2010;9:971–82.10.1586/erv.10.87Suche in Google Scholar

24. Sala F, Rigano MM, Barbante A, Basso B, Walmsley AM, Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 2003;21:803–8.10.1016/S0264-410X(02)00603-5Suche in Google Scholar

25. Mooney BP. The second green revolution Production of plant-based biodegradable plastics. Biochem J 2009;418:219–32.10.1042/BJ20081769Suche in Google Scholar PubMed

26. Sharma AK, Sharma MK. Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv 2009;27:811–32.10.1016/j.biotechadv.2009.06.004Suche in Google Scholar PubMed PubMed Central

27. Bhatla SC, Kaushik V, Yadav MK. Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Biotechnol Adv 2010;28:293–300.10.1016/j.biotechadv.2010.01.001Suche in Google Scholar PubMed

28. Ling H. Oleosin fusion expression systems for the production of recombinant proteins. Biologia 2007;62:119–23.10.2478/s11756-007-0041-4Suche in Google Scholar

29. Parmenter DL, Boothe JG, Van Rooijen GJ, Yeung EC, Moloney MM. Production of biologically active hirudin in plants seeds using oleosin partitioning. Plant Mol Biol 1995;29:1167–80.10.1007/BF00020460Suche in Google Scholar PubMed

30. Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren J, Markley NA. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 2006;4:77–85.10.1111/j.1467-7652.2005.00159.xSuche in Google Scholar PubMed

31. Chaudhary S, Parmenter DL, Moloney MM. Transgenic Brassica carinata as a vehicle for the production of recombinant proteins in seeds. Plant Cell Rep 1998;17:195–200.10.1007/s002990050377Suche in Google Scholar PubMed

32. Van Rooijen GJ, Moloney MM. Plant seed oil-bodies as carriers for foreign proteins. Biotechnology 1995;13:72–7.10.1038/nbt0195-72Suche in Google Scholar PubMed

33. Moloney MM, Van-Rooijen GJ. Expression of epidermal growth factor in plant seeds. Patent No.7091401. Sembiosys Genetics Inc. 2006.Suche in Google Scholar

34. Yang J, Guan LL, Guo YX, Du LN, Wang FW, Wang YF, et al. Express ion of biologically recombinant human acidic fibroblast growth factor in Arabidopsis thaliana seeds via oleosin fusion technology. Gene 2015;566:89–94.10.1016/j.gene.2015.04.036Suche in Google Scholar PubMed

35. Yi SY, Yang J, Huang J, Guan LL, Du LN, Guo YX, et al. Expression of bioactive recombinant human fibroblast growth factor 9 in oil bodies of Arabidopsis thaliana. Protein Expr Purif 2015;116:127–32.10.1016/j.pep.2015.08.006Suche in Google Scholar PubMed

36. Höfgen R, Willmitzer L. Storage of competent cells for Agrobacterium transformation. Nucleic Acids Res 1988;16:9877.10.1093/nar/16.20.9877Suche in Google Scholar PubMed PubMed Central

37. Li HR, Yang J, Chen YB, Guan LL, Du LN, Guo Y, et al. Expression of a functional recombinant oleosin-human hyaluronidase hPH20 fusion in Arabidopsis thaliana. Protein Expr Purif 2014;103:23–7.10.1016/j.pep.2014.03.007Suche in Google Scholar PubMed

38. Song LT, Huang ZF, Chen Y, Li HY, Jiang C, Li XK. High-efficiency production of bioactive recombinant human fibroblast growth factor 18 in Escherichia coli and its effects on hair follicle growth. Appl Microbiol Biotechnol 2014;98:695–704.10.1007/s00253-013-4929-3Suche in Google Scholar PubMed

39. Zhao L, Chen YM, Chen YJ, Kong XZ, Hua YF. Effects of pH on protein components of extracted oil bodies from diverse plant seeds and endogenous protease-induced oleosin hydrolysis. Food Chem 2016;200:125–33.10.1016/j.foodchem.2016.01.034Suche in Google Scholar PubMed

40. Huang J, Yang J, Guan LL, Yi SY, Du LN, Tian H, et al. Expression of bioactive recombinant human fibroblast growth factor 10 in Carthamus tinctorius L. seeds. Protein Expr Purif 2017;138:7–12.10.1016/j.pep.2015.09.016Suche in Google Scholar PubMed

Received: 2017-12-25
Accepted: 2018-03-27
Published Online: 2018-08-15
Published in Print: 2019-05-01

©2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Short Communication
  3. Acetone-water mixture is a competent solvent to extract phenolics and antioxidants from four organs of Eucalyptus camaldulensis
  4. Research Articles
  5. Proteases from Calotropis gigantea stem, leaf and calli as milk coagulant source
  6. A new method to quantify atmospheric Poaceae pollen DNA based on the trnT-F cpDNA region
  7. Expression of a functional recombinant vascular endothelial growth factor 165 (VEGF165) in Arabidopsis thaliana
  8. Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus
  9. Investigation of antioxidant, cytotoxic, tyrosinase inhibitory activities, and phenolic profiles of green, white, and black teas
  10. DFR and PAL gene transcription and their correlation with anthocyanin accumulation in Rhodomyrtus tomentosa (Aiton.) Hassk.
  11. Comparison of phenolic profiles and antioxidant activity of three Ornithogalum L. species
  12. Increasing the fermentation efficiency of Lactobacillus paracasei ssp. paracasei MIUG BL6 in a rye flour sourdough
  13. Determination of chemical composition, antibacterial and antioxidant properties of products obtained from carob and honey locust
  14. Chitinolytic Bacillus subtilis Ege-B-1.19 as a biocontrol agent against mycotoxigenic and phytopathogenic fungi
  15. Recycling fish skin for utilization in food industry as an effective emulsifier and foam stabilizing agent
  16. A novel, thermotolerant, extracellular PHB depolymerase producer Paenibacillus alvei PHB28 for bioremediation of biodegradable plastics
  17. Post-transcriptional regulation of miRNA-15a and miRNA-15b on VEGFR gene and deer antler cell proliferation
  18. Comparison of pendimethalin binding properties of serum albumins from various mammalian species
  19. Crocin (active constituent of saffron) improves CCl4-induced liver damage by modulating oxidative stress in rats
  20. Time dependent change of ethanol consumption biomarkers, ethyl glucuronide and ethyl sulphate, after single dose ethanol intake
  21. GC-MS analysis and biological activities of Thymus vulgaris and Mentha arvensis essential oil
  22. Immobilization and some application of α-amylase purified from Rhizoctonia solani AG-4 strain ZB-34
  23. Letter to the Editor
  24. Molecular crosstalk between Hog1 and calcium/CaM signaling
https://doi.org/10.1515/tjb-2017-0368
Schlagwörter für diesen Artikel
Vascular endothelial growth factor 165; Oil body; Oleosin; Arabidopsis thaliana

Artikel in diesem Heft

  1. Frontmatter
  2. Short Communication
  3. Acetone-water mixture is a competent solvent to extract phenolics and antioxidants from four organs of Eucalyptus camaldulensis
  4. Research Articles
  5. Proteases from Calotropis gigantea stem, leaf and calli as milk coagulant source
  6. A new method to quantify atmospheric Poaceae pollen DNA based on the trnT-F cpDNA region
  7. Expression of a functional recombinant vascular endothelial growth factor 165 (VEGF165) in Arabidopsis thaliana
  8. Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus
  9. Investigation of antioxidant, cytotoxic, tyrosinase inhibitory activities, and phenolic profiles of green, white, and black teas
  10. DFR and PAL gene transcription and their correlation with anthocyanin accumulation in Rhodomyrtus tomentosa (Aiton.) Hassk.
  11. Comparison of phenolic profiles and antioxidant activity of three Ornithogalum L. species
  12. Increasing the fermentation efficiency of Lactobacillus paracasei ssp. paracasei MIUG BL6 in a rye flour sourdough
  13. Determination of chemical composition, antibacterial and antioxidant properties of products obtained from carob and honey locust
  14. Chitinolytic Bacillus subtilis Ege-B-1.19 as a biocontrol agent against mycotoxigenic and phytopathogenic fungi
  15. Recycling fish skin for utilization in food industry as an effective emulsifier and foam stabilizing agent
  16. A novel, thermotolerant, extracellular PHB depolymerase producer Paenibacillus alvei PHB28 for bioremediation of biodegradable plastics
  17. Post-transcriptional regulation of miRNA-15a and miRNA-15b on VEGFR gene and deer antler cell proliferation
  18. Comparison of pendimethalin binding properties of serum albumins from various mammalian species
  19. Crocin (active constituent of saffron) improves CCl4-induced liver damage by modulating oxidative stress in rats
  20. Time dependent change of ethanol consumption biomarkers, ethyl glucuronide and ethyl sulphate, after single dose ethanol intake
  21. GC-MS analysis and biological activities of Thymus vulgaris and Mentha arvensis essential oil
  22. Immobilization and some application of α-amylase purified from Rhizoctonia solani AG-4 strain ZB-34
  23. Letter to the Editor
  24. Molecular crosstalk between Hog1 and calcium/CaM signaling
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 19.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/tjb-2017-0368/html
Button zum nach oben scrollen